T

Transgene Biotek Limited

TRABI
Market snapshot · 2026-08-10 19:07 UTC

2.94

+₹0.03 (+1.03%)

MARKET CAP

₹22.28 Cr

STOCK P/E

52W HIGH

₹5.10

52W LOW

₹1.83

BOOK VALUE

₹1.11

EPS

₹-0.22

ROE

-17.96%

SECTOR

Health Care

DEBT/EQUITY

204.57

VOLUME

5,223

P/B RATIO

2.66x

PEG RATIO

Sector

Health Care

Themes

Biotechnology
₹4.46₹3.87₹3.29₹2.70₹2.11VolumeAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Valuation Metrics

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

P/S
Strongly Overvalued

5Y Average

87.49

Current

105.48

Overvalued

93.99

Undervalued

81.62

P/B
Undervalued

5Y Average

2.73

Current

2.66

Overvalued

3.13

Undervalued

2.32

Peers & Comparison

No peer data available for this company.
WHY THESE PEERS

No sector data available for this company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹0.00 CrMar 2026

Latest net profit

₹0.00 CrMar 2026

Latest EPS

₹-0.06Mar 2026

Net margin

-605.5%Mar 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26-750.0%-600.0%-450.0%-300.0%-150.0%-1.00 Cr-0.75 Cr-0.50 Cr-0.25 Cr0.00 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.00 Cr1.00 Cr2.00 Cr3.00 Cr4.00 Cr₹-0₹-0₹-0₹-0₹-0
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOperatingprofitOther incomeInterestProfitbefore taxTax & otherNet Profit0.00 Cr1.00 Cr2.00 Cr3.00 Cr4.00 Cr

Latest reported period: Mar 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2025Sep 2025Mar 2026-50 Cr0.00 Cr50 Cr100 Cr150 Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

Sales

₹0 Cr

-28.8%

Net Profit

₹-0 Cr

+35.9%

EBITDA

₹-0 Cr

+73.8%

EPS

₹-0.06

+33.3%
MetricDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales00000
Expenses10000
Operating Profit-1-0-0-0-0
OPM %-739.48%-380.2%-235.04%-183.85%-605.5%
Other Income000
Interest00000
Depreciation00000
Profit before tax-1-0-0-0-0
Tax %-0.0%-0.0%-0.0%-0.0%-0.0%
Net Profit-1-0-0-0-0
EPS in Rs-0.09-0.06-0.05-0.05-0.06

All values in ₹ Crores unless otherwise stated. Source: Company filings.

Loading shareholding pattern...